[Retracted] USP21 Promotes the Progression of Nasopharyngeal Carcinoma by Regulating FOXM1

Figure 1

Knockdown of USP21 inhibited proliferation of nasopharyngeal carcinoma cells. (a) The USP21 transcript clinical data of nasopharyngeal carcinoma expression profile data in TCGA database. (b, c) The mRNA and protein expression levels of USP21 in tumor tissues and adjacent tissues of nasopharyngeal carcinoma patients. (d) The protein expression levels of USP21 in human normal human nasopharyngeal epithelial cell line (NP69) and three nasopharyngeal carcinoma cell lines (C666-1, SUNE-1, and 5-8F). (e) Knockdown of USP21 in C666-1 and 5-8F nasopharyngeal carcinoma cell lines was verified by western blot. (f, g) Serial CCK-8 and EdU cell viability assays were used to detect the proliferation of C666-1 and 5-8F nasopharyngeal carcinoma cell lines after knocking down USP21. Data was presented as the with three independent experiments. and versus the control group.

(a)

(b)

(c)

(d)

(e)

(f)

(g)